Mark Holodniy

16.4k total citations · 3 hit papers
237 papers, 9.5k citations indexed

About

Mark Holodniy is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mark Holodniy has authored 237 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Infectious Diseases, 87 papers in Epidemiology and 75 papers in Virology. Recurrent topics in Mark Holodniy's work include HIV/AIDS drug development and treatment (79 papers), HIV Research and Treatment (73 papers) and HIV/AIDS Research and Interventions (65 papers). Mark Holodniy is often cited by papers focused on HIV/AIDS drug development and treatment (79 papers), HIV Research and Treatment (73 papers) and HIV/AIDS Research and Interventions (65 papers). Mark Holodniy collaborates with scholars based in United States, Canada and United Kingdom. Mark Holodniy's co-authors include Mark A. Winters, David Katzenstein, Douglas K Owens, Sarah C. Heilshorn, Jordan Raphel, Stuart B. Goodman, Hongjie Dai, Zhuang Liu, Andrew Zolopa and Edwin D. Charlebois and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Mark Holodniy

230 papers receiving 9.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

2000 864 citations Mark Holodniy et al. profile →
Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning

2019 592 citations Mark Holodniy et al. profile →
Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants

2016 562 citations Mark Holodniy et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Holodniy	4.9k	2.8k	2.8k	1.1k	1.1k	237	9.5k
Patrizio Pezzotti	4.8k 1.0×	3.3k 1.2×	1.9k 0.7×	809 0.7×	198 0.2×	289	10.6k
Robert L. Murphy	7.2k 1.5×	3.5k 1.2×	5.6k 2.0×	1.7k 1.5×	291 0.3×	417	14.6k
Gilbert Greub	5.4k 1.1×	5.6k 2.0×	1.3k 0.5×	4.7k 4.3×	832 0.8×	492	18.5k
Robert T. Schooley	3.6k 0.7×	3.0k 1.1×	3.4k 1.2×	1.8k 1.7×	326 0.3×	197	11.3k
Laurent Kaiser	7.2k 1.5×	6.7k 2.4×	1.6k 0.6×	1.3k 1.2×	457 0.4×	371	14.4k
Giuseppe Ippolito	10.9k 2.2×	6.6k 2.3×	2.7k 1.0×	2.1k 1.9×	263 0.2×	533	18.4k
Charles A. Boucher	9.7k 2.0×	4.2k 1.5×	9.1k 3.3×	1.5k 1.4×	622 0.6×	345	17.4k
Angela M. Caliendo	4.8k 1.0×	5.4k 1.9×	2.6k 0.9×	810 0.7×	563 0.5×	185	10.6k
Daniel R. Kuritzkes	14.3k 2.9×	3.2k 1.1×	13.9k 5.0×	2.7k 2.4×	1.3k 1.2×	370	19.9k
Stephen A. Spector	7.6k 1.6×	7.9k 2.8×	6.5k 2.3×	1.5k 1.3×	246 0.2×	319	16.2k

Countries citing papers authored by Mark Holodniy

Since Specialization

Citations

This map shows the geographic impact of Mark Holodniy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holodniy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holodniy more than expected).

Fields of papers citing papers by Mark Holodniy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holodniy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holodniy. The network helps show where Mark Holodniy may publish in the future.

Co-authorship network of co-authors of Mark Holodniy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Holodniy. A scholar is included among the top collaborators of Mark Holodniy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Holodniy. Mark Holodniy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holodniy, Mark, et al.. (2024). An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV). Expert Review of Clinical Pharmacology. 17(7). 589–614. 1 indexed citations

Oda, Gina, Cynthia Lucero‐Obusan, Patricia Schirmer, Joyce Chung, & Mark Holodniy. (2024). Risk Factors for Extrapulmonary Tuberculosis Among US Veterans, 1990–2022. Open Forum Infectious Diseases. 11(12). ofae698–ofae698. 1 indexed citations

Cates, Jordan, Cristina V. Cardemil, Sara A. Mirza, et al.. (2023). Risk of Hospitalization and Mortality Following Medically Attended Norovirus Infection—Veterans Health Administration, 2010–2018. Open Forum Infectious Diseases. 10(11). ofad556–ofad556. 1 indexed citations

Lucero‐Obusan, Cynthia, et al.. (2023). Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration. The Journal of Infectious Diseases. 229(Supplement_2). S172–S180. 2 indexed citations

Lucero‐Obusan, Cynthia, Rishi Deka, Patricia Schirmer, Gina Oda, & Mark Holodniy. (2023). Epidemiology of Coccidioidomycosis in the Veterans Health Administration, 2013–2022. Journal of Fungi. 9(7). 731–731. 3 indexed citations

Young‐Xu, Yinong, Héctor S. Izurieta, Caroline Korves, et al.. (2022). Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case–control study among US veterans. BMJ Open. 12(8). e063935–e063935. 20 indexed citations

Rentsch, Christopher T., Farah Kidwai‐Khan, Janet P. Tate, et al.. (2020). Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study. PLoS Medicine. 17(9). e1003379–e1003379. 234 indexed citations

Cardemil, Cristina V., Rebecca M. Dahl, Mila M. Prill, et al.. (2020). COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study. JMIR Public Health and Surveillance. 7(1). e24502–e24502. 20 indexed citations

Holodniy, Mark, Marie A. de Perio, Kiran M. Perkins, et al.. (2019). Notes from the Field: Unexplained Dermatologic, Respiratory, and Ophthalmic Symptoms Among Health Care Personnel at a Hospital — West Virginia, November 2017–January 2018. MMWR Morbidity and Mortality Weekly Report. 68(44). 1006–1007. 1 indexed citations

10.

Oda, Gina, et al.. (2019). Carbon monoxide poisoning surveillance in the Veterans Health Administration, 2010–2017. BMC Public Health. 19(1). 190–190. 7 indexed citations

11.

Rhee, Soo‐Yon, Kris Sankaran, Vici Varghese, et al.. (2016). HIV-1 Protease, Reverse Transcriptase, and Integrase Variation. Journal of Virology. 90(13). 6058–6070. 68 indexed citations

12.

Liu, Shan, Lauren E. Cipriano, Mark Holodniy, Douglas K Owens, & Jeremy D. Goldhaber‐Fiebert. (2012). New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Author Names. Annals of Internal Medicine. 156(4). 279. 1 indexed citations

13.

Holodniy, Mark, Gina Oda, Patricia Schirmer, et al.. (2012). Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment. Infection Control and Hospital Epidemiology. 33(7). 649–656. 2 indexed citations

14.

Hsu, Joe L., Andrew Siroka, Mark W. Smith, Mark Holodniy, & G. Umberto Meduri. (2011). One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. International Journal of Infectious Diseases. 15(6). e382–e387. 34 indexed citations

15.

Ayers, Dieter, Joel Singer, P. Richard Harrigan, et al.. (2010). Connection Domain Mutations in Treatment-Experienced Patients in the OPTIMA Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(2). 160–166. 16 indexed citations

16.

Davey, Richard T., Peter Pertel, Alice Benson, et al.. (2008). Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy. Journal of Interferon & Cytokine Research. 28(2). 89–100. 5 indexed citations

17.

Holodniy, Mark, et al.. (2006). Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004). JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(1). 20–29. 23 indexed citations

18.

Holodniy, Mark. (1998). Phenotypic and Genotypic Testing in Clinical Practice. AIDS Patient Care and STDs. 12(7). 527–531. 1 indexed citations

19.

Frost, Kevin R., Paul Bellman, Calvin Cohen, et al.. (1998). Question and Answer Session. AIDS Patient Care and STDs. 12(7). 557–566. 1 indexed citations

20.

Owens, Douglas K, Mark Holodniy, Alan M. Garber, et al.. (1996). Polymerase Chain Reaction for the Diagnosis of HIV Infection in Adults. Annals of Internal Medicine. 126. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact